Scientists find some human cancers to be 'evolutionary accidents'

April 17, 2018, University of Liverpool
Credit: CC0 Public Domain

New research, published in Biological Reviews and conducted by researchers from the University of Liverpool and Escola Superior de Ciências da Saúde (Brasília, Brazil) has found some type of cancers unique to humans may be a result of evolutionary accidents.

Cancer is a major cause of death worldwide. But humans are not the only species affected by ; in fact, only a few primitive animals are thought to escape the disease. Furthermore, incidence rates and cancer types differ widely among species. However, how cancer patterns in humans compare to those of other species remains largely unknown.

Researchers, led by Dr Joao Pedro De Magalhaes from the University of Liverpool's Institute of Ageing and Chronic Disease, aimed to identify further clues about cancer and its evolutionary underpinnings in humans and across a wide range of animals by conducting the largest survey of animal cancer data to date.

The researchers began examining data relating to primates then continued onto other mammals before examining cancer in birds, amphibians, reptiles, fish and finally invertebrates and plants. They then reviewed the cancer incidence and types for humans and animal types.

They found that some types of cancer are widespread across nearly all species, like blood cancers (lymphomas and leukaemia), and there are some types of cancer that seem to be unique of humans, like lung cancer, prostate and testicular cancers. These could be evolutionary accidents, a product of random events in the evolution of our species.

Dr De Magalhaes, said: "Perhaps unique mutations during the evolution of the lineage contribute to the disproportionately high incidence of some cancers in our species when compared to all other studied species."

Another hypothesis is that the increasing life expectancy of humans is allowing the appearance of cancers that would not have affected our ancestors.

First author Thales Albuquerque, said: "Cancer rates among humans are high, and they are bound to keep increasing. We still do not know all mechanisms that lead to such a high incidence of cancer in our species, but one hypothesis is that cultural changes and technological advances have produced the greatest of evolutionary mismatches - a situation where the environment changes into something different from that which a is adapted to, and that provokes stress and may increase susceptibility to cancer.

Dr De Magalhaes: "Our work highlights the different evolutionary pressures acting on cancer early in life (with a high prevalence of presumably driven by the need to fight pathogens) and cancer late in life that escapes natural selection, including human-specific cancers that may be evolutionary accidents or related to a mismatch with the modern environment and lifestyle."

Explore further: Cold discomfort: Increasing cancer rates and adaptation of living in extreme environments

More information: Thales A. F. Albuquerque et al, From humans to hydra: patterns of cancer across the tree of life, Biological Reviews (2018). DOI: 10.1111/brv.12415

Related Stories

Cold discomfort: Increasing cancer rates and adaptation of living in extreme environments

December 5, 2017
It is well known that cancer incidence is increasing worldwide, with pockets of human populations and geographical locations seemingly at higher risk than others.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Chimera viruses can help the fight against lymphomas

September 15, 2017
Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

Recommended for you

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.